IL86676A - Cell line and monoclonal antibody which binds to a specific antigenic site expressed on the surface of phagocytic cells - Google Patents

Cell line and monoclonal antibody which binds to a specific antigenic site expressed on the surface of phagocytic cells

Info

Publication number
IL86676A
IL86676A IL86676A IL8667688A IL86676A IL 86676 A IL86676 A IL 86676A IL 86676 A IL86676 A IL 86676A IL 8667688 A IL8667688 A IL 8667688A IL 86676 A IL86676 A IL 86676A
Authority
IL
Israel
Prior art keywords
monoclonal antibody
binds
antigenic site
cell line
phagocytic cells
Prior art date
Application number
IL86676A
Other languages
English (en)
Other versions
IL86676A0 (en
Original Assignee
Dana Farber Cancer Inst Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dana Farber Cancer Inst Inc filed Critical Dana Farber Cancer Inst Inc
Publication of IL86676A0 publication Critical patent/IL86676A0/xx
Publication of IL86676A publication Critical patent/IL86676A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C07K16/2845—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta2-subunit-containing molecules, e.g. CD11, CD18
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/828—Cancer

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL86676A 1987-07-06 1988-06-09 Cell line and monoclonal antibody which binds to a specific antigenic site expressed on the surface of phagocytic cells IL86676A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7025787A 1987-07-06 1987-07-06
US07/165,024 US5019648A (en) 1987-07-06 1988-03-07 Monoclonal antibody specific for the adhesion function domain of a phagocyte cell surface protein

Publications (2)

Publication Number Publication Date
IL86676A0 IL86676A0 (en) 1988-11-30
IL86676A true IL86676A (en) 1992-06-21

Family

ID=26750961

Family Applications (1)

Application Number Title Priority Date Filing Date
IL86676A IL86676A (en) 1987-07-06 1988-06-09 Cell line and monoclonal antibody which binds to a specific antigenic site expressed on the surface of phagocytic cells

Country Status (15)

Country Link
US (1) US5019648A (de)
EP (1) EP0357672B1 (de)
JP (1) JPH03501560A (de)
KR (1) KR960009013B1 (de)
CN (1) CN1028114C (de)
AT (1) ATE121130T1 (de)
AU (1) AU616182B2 (de)
CA (1) CA1340015C (de)
DE (1) DE3853588T2 (de)
DK (1) DK3390A (de)
ES (1) ES2013338A6 (de)
IE (1) IE61392B1 (de)
IL (1) IL86676A (de)
MX (1) MX9203245A (de)
WO (1) WO1989000190A1 (de)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5019648A (en) * 1987-07-06 1991-05-28 Dana-Farber Cancer Institute Monoclonal antibody specific for the adhesion function domain of a phagocyte cell surface protein
US5219997A (en) * 1987-07-06 1993-06-15 Dana-Farber Cancer Institute Monoclonal antibody which inhibits the adhesion functions of the β integrin, CR3
US5179019A (en) * 1988-03-31 1993-01-12 Biomedical Systems Limited Therapeutic murine monoclonal antibody
US5272263A (en) * 1989-04-28 1993-12-21 Biogen, Inc. DNA sequences encoding vascular cell adhesion molecules (VCAMS)
US5217870A (en) * 1989-04-28 1993-06-08 Biogen, Inc. Monoclonal antibodies against CDX
GB9115364D0 (en) * 1991-07-16 1991-08-28 Wellcome Found Antibody
US5708141A (en) * 1992-05-11 1998-01-13 Corvas International, Inc. Neutrophil inhibitors
CA2135390A1 (en) 1992-05-11 1993-11-25 Matthew Moyle Novel neutrophil inhibitors
DK0642577T3 (da) * 1992-05-22 2004-07-19 Univ Montana State Antistoffer med specificitet for multiple adhæsionsmolekyler
JPH08502956A (ja) * 1992-10-09 1996-04-02 センター、フォー、ブラッド、リサーチ、インコーポレーテッド ＩＣＡＭ‐１及びフィブリノーゲンへの好中球接着を媒介するＭａｃ‐１（ＣＤ１１ｂ／ＣＤ１８）分子のサブ集団
US7083979B1 (en) * 1994-03-25 2006-08-01 Indiana University Foundation Methods for enhanced retroviral-mediated gene transfer
US5656441A (en) * 1994-04-19 1997-08-12 Trustees Of Boston University Methods for determining cellular adhesion
US5834889A (en) * 1995-09-22 1998-11-10 Gl Displays, Inc. Cold cathode fluorescent display
US6001356A (en) * 1995-09-29 1999-12-14 Rush-Presbyterian-St. Luke's Medical Center Method of inhibiting tissue destruction in autoimmune disease using anti-CD44 antibodies
DE19739879A1 (de) * 1996-09-19 1998-03-26 Zeiss Carl Fa Kippvorrichtung
AU4574501A (en) 2000-03-17 2001-10-03 Millennium Pharm Inc Method of inhibiting stenosis and restenosis
US8914114B2 (en) 2000-05-23 2014-12-16 The Feinstein Institute For Medical Research Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
CA2476896A1 (en) * 2002-02-26 2003-09-04 North Shore-Long Island Jewish Research Institute Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors
US10912712B2 (en) 2004-03-25 2021-02-09 The Feinstein Institutes For Medical Research Treatment of bleeding by non-invasive stimulation
CA2560756A1 (en) 2004-03-25 2005-10-06 The Feinstein Institute For Medical Research Methods and devices for reducing bleed time using vagus nerve stimulation
DE602005025020D1 (de) 2004-12-27 2011-01-05 The Feinstein Inst Medical Res Behandlung von entzündlichen erkrankungen durch el
US11207518B2 (en) 2004-12-27 2021-12-28 The Feinstein Institutes For Medical Research Treating inflammatory disorders by stimulation of the cholinergic anti-inflammatory pathway
US8391970B2 (en) * 2007-08-27 2013-03-05 The Feinstein Institute For Medical Research Devices and methods for inhibiting granulocyte activation by neural stimulation
US9211409B2 (en) * 2008-03-31 2015-12-15 The Feinstein Institute For Medical Research Methods and systems for reducing inflammation by neuromodulation of T-cell activity
US9662490B2 (en) 2008-03-31 2017-05-30 The Feinstein Institute For Medical Research Methods and systems for reducing inflammation by neuromodulation and administration of an anti-inflammatory drug
ES2452484T3 (es) 2008-11-18 2014-04-01 Setpoint Medical Corporation Dispositivos para optimizar la colocación de electrodos para la estimulación antiinflamatoria
US9211410B2 (en) 2009-05-01 2015-12-15 Setpoint Medical Corporation Extremely low duty-cycle activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
US20110054569A1 (en) * 2009-09-01 2011-03-03 Zitnik Ralph J Prescription pad for treatment of inflammatory disorders
US8996116B2 (en) 2009-10-30 2015-03-31 Setpoint Medical Corporation Modulation of the cholinergic anti-inflammatory pathway to treat pain or addiction
CN102573986B (zh) 2009-06-09 2016-01-20 赛博恩特医疗器械公司 用于无导线刺激器的具有袋部的神经封套
US9833621B2 (en) 2011-09-23 2017-12-05 Setpoint Medical Corporation Modulation of sirtuins by vagus nerve stimulation
WO2014169145A1 (en) 2013-04-10 2014-10-16 Setpoint Medical Corporation Closed-loop vagus nerve stimulation
CN102821814B (zh) 2009-12-23 2015-07-15 赛博恩特医疗器械公司 用于治疗慢性炎症的神经刺激设备和系统
US12172017B2 (en) 2011-05-09 2024-12-24 Setpoint Medical Corporation Vagus nerve stimulation to treat neurodegenerative disorders
WO2012154865A2 (en) 2011-05-09 2012-11-15 Setpoint Medical Corporation Single-pulse activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
US9572983B2 (en) 2012-03-26 2017-02-21 Setpoint Medical Corporation Devices and methods for modulation of bone erosion
US11311725B2 (en) 2014-10-24 2022-04-26 Setpoint Medical Corporation Systems and methods for stimulating and/or monitoring loci in the brain to treat inflammation and to enhance vagus nerve stimulation
WO2016126807A1 (en) 2015-02-03 2016-08-11 Setpoint Medical Corporation Apparatus and method for reminding, prompting, or alerting a patient with an implanted stimulator
US10596367B2 (en) 2016-01-13 2020-03-24 Setpoint Medical Corporation Systems and methods for establishing a nerve block
CN108882885A (zh) 2016-01-20 2018-11-23 赛博恩特医疗器械公司 迷走神经刺激的控制
WO2017127758A1 (en) 2016-01-20 2017-07-27 Setpoint Medical Corporation Implantable microstimulators and inductive charging systems
US11471681B2 (en) 2016-01-20 2022-10-18 Setpoint Medical Corporation Batteryless implantable microstimulators
US10583304B2 (en) 2016-01-25 2020-03-10 Setpoint Medical Corporation Implantable neurostimulator having power control and thermal regulation and methods of use
WO2018109667A1 (en) 2016-12-15 2018-06-21 Nestec Sa Compositions and methods that modulate white blood cells or neutrophils in a companion animal
WO2019036470A1 (en) 2017-08-14 2019-02-21 Setpoint Medical Corporation TESTING TEST FOR STIMULATION OF NERVE WAVE
US11260229B2 (en) 2018-09-25 2022-03-01 The Feinstein Institutes For Medical Research Methods and apparatuses for reducing bleeding via coordinated trigeminal and vagal nerve stimulation
US12343535B2 (en) 2019-04-12 2025-07-01 Setpoint Medical Corporation Vagus nerve stimulation to treat neurodegenerative disorders
JP2023512447A (ja) 2020-01-13 2023-03-27 ザ ファインスタイン インスティチューツ フォー メディカル リサーチ 脾臓への高密度集束超音波刺激による出血及び出血性疾患の治療
US11938324B2 (en) 2020-05-21 2024-03-26 The Feinstein Institutes For Medical Research Systems and methods for vagus nerve stimulation
US12444497B2 (en) 2021-05-17 2025-10-14 Setpoint Medical Corporation Neurostimulation parameter authentication and expiration system for neurostimulation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4935234A (en) * 1987-06-11 1990-06-19 Dana-Farber Cancer Institute Method of reducing tissue damage at an inflammatory site using a monoclonal antibody
US4840793A (en) * 1987-06-11 1989-06-20 Dana-Farber Cancer Institute Method of reducing tissue damage at an inflammatory site using a monoclonal antibody
US5019648A (en) * 1987-07-06 1991-05-28 Dana-Farber Cancer Institute Monoclonal antibody specific for the adhesion function domain of a phagocyte cell surface protein

Also Published As

Publication number Publication date
IE881357L (en) 1989-01-06
JPH03501560A (ja) 1991-04-11
EP0357672A1 (de) 1990-03-14
AU616182B2 (en) 1991-10-24
ATE121130T1 (de) 1995-04-15
EP0357672A4 (de) 1990-06-05
CA1340015C (en) 1998-08-25
DE3853588D1 (de) 1995-05-18
IE61392B1 (en) 1994-11-02
KR960009013B1 (ko) 1996-07-10
IL86676A0 (en) 1988-11-30
EP0357672B1 (de) 1995-04-12
US5019648A (en) 1991-05-28
WO1989000190A1 (en) 1989-01-12
DK3390D0 (da) 1990-01-05
KR890701734A (ko) 1989-12-21
MX9203245A (es) 1992-07-01
AU1721888A (en) 1989-01-30
CN1028114C (zh) 1995-04-05
DK3390A (da) 1990-03-05
ES2013338A6 (es) 1990-05-01
DE3853588T2 (de) 1995-11-23
CN1030611A (zh) 1989-01-25

Similar Documents

Publication Publication Date Title
IL86676A (en) Cell line and monoclonal antibody which binds to a specific antigenic site expressed on the surface of phagocytic cells
AU3615384A (en) Method of detecting immiune complexes in serium
PH16642A (en) Complement-fixing monoclonal antibody to human t cells,and methods of preparing same
ES8606663A1 (es) Un procedimiento de ensayo inmunometrico para detectar la presencia de al menos dos antigenos en una muestra
FI810027L (fi) Hybridcellinje foer framstaellning av en monoklonal antikropp mot en maensklig monosytantigen den saolunda framstaellda antikroppen samt foerfaranden i vilka antikroppen anvaends
CA2093928A1 (en) Monoclonal antibodies for detection and treatment of cancer
GB8504104D0 (en) Hcmv monoclonal antibodies
NZ211989A (en) Monoclonal anticytomegalovirus antibodies and diagnostic system
DE3480494D1 (en) Method and reagent for use in the assay of pivka-ii
EP0178891A3 (de) Human-humane Hybridzellinien die Antikörper gegen Antigendeterminanten von Krebszellen produzieren
NO883495D0 (no) Mot neutrofili spesifikt monoklonalt antistoff.
KR960014336A (ko) 사람 글리센틴에 대한 모노클로날 항체, 이러한 항체를 생성하기 위한 하이브리도마 및 상기 항체를 사용한 사람 글리센틴의 검정방법
AU6939687A (en) Assays for myasthenia gravis and substrates and kits for use therein
EP0335134A3 (de) Monoklonale Antikörper von Mäusen gegen das gp41 Protein von menschlichem Immunmangelsyndrom-Virus
EP0109012A3 (de) Bestimmung von Streptococci
NZ306622A (en) Method for diagnosing a patient for chlamydia
EP0323802A3 (de) Gegen Lungenkrebs gerichtete monoklonale Antikörper und Zelloberflächenantigen davon
AU4661293A (en) Peptides representing antigenic epitopes of ige present on b cell but not basophil surface
EP0248147A3 (de) Verfahren zur Bestimmung der Anwesenheit von Krebszellen
IE881273L (en) Monoclonal antibodies
ES8802545A1 (es) Un metodo para determinar prolil 4-hidroxilasa humana por inmunoensayo enzimatico o radioinmunoensayo
NO873154L (no) Spesifikke monoklonale antistoffer mot overflatereseptor for ige og hybridcellelinjer som produserer disse antistoffer og anvendelse derav.
ES8705232A1 (es) Un metodo para preparar un anticuerpo monoclonal destinado autilizarse como auxiliar de diagnostico para detectar cancerde pulmon
WO1990008956A1 (en) Detection of human tissue factor activator
IE882250L (en) Monoclonal antibodies and methods for diagnosis of Phytophthora infection

Legal Events

Date Code Title Description
RH Patent void